Small molecule induced STING degradation facilitated by the HECT ligase HERC4.
Merve MutluIsabel SchmidtAndrew I MorrisonBenedikt GoretzkiFelix FreulerDamien BegueOliver SimicNicolas PythoudErik AhrneSandra KappsSusan RoestDebora BonenfantDelphine JeanpierreThi-Thanh-Thao TranRob MaherShaojian AnAmandine RietschFlorian NigschAndreas HofmannJohn Reece-HoyesChristian N ParkerDanilo GueriniPublished in: Nature communications (2024)
Stimulator of interferon genes (STING) is a central component of the cytosolic nucleic acids sensing pathway and as such master regulator of the type I interferon response. Due to its critical role in physiology and its' involvement in a variety of diseases, STING has been a focus for drug discovery. Targeted protein degradation (TPD) has emerged as a promising pharmacology for targeting previously considered undruggable proteins by hijacking the cellular ubiquitin proteasome system (UPS) with small molecules. Here, we identify AK59 as a STING degrader leveraging HERC4, a HECT-domain E3 ligase. Additionally, our data reveals that AK59 is effective on the common pathological STING mutations, suggesting a potential clinical application of this mechanism. Thus, these findings introduce HERC4 to the fields of TPD and of compound-induced degradation of STING, suggesting potential therapeutic applications.